首页    期刊浏览 2024年10月07日 星期一
登录注册

文章基本信息

  • 标题:Perigos do consumo da sibutramina como inibidora de apetite
  • 本地全文:下载
  • 作者:Márcio Gomes da Silva ; Thalysson Pereira Rosa ; Yolanda de Jesus Morais
  • 期刊名称:Research, Society and Development
  • 电子版ISSN:2525-3409
  • 出版年度:2021
  • 卷号:10
  • 期号:13
  • 页码:1-9
  • DOI:10.33448/rsd-v10i13.20802
  • 语种:English
  • 出版社:Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
  • 摘要:Introduction: Sibutramine is a drug used to treat obesity, a drug with a black stripe, because of the way it acts on the brain and acts quickly increasing the feeling of satiety Consumed most often by women in search of the perfect body. Objective: The aim of the study was to analyze the dangers of sibutramine in weight loss and the effects that occur in the body. Material and Methods: The study was conducted through a literature review and aims to explain the dangers that occur when this drug is consumed incorrectly, inhibiting the appetite for weight loss. Articles with a time limit from 2015 to 2021 were selected. The study took place from February to July 2021, in the databases of the Virtual Health Library (VHL), the Latin American and Caribbean Literature on Health Sciences (LILACS) and in Scientific Electronic Library Online (SciELO). Results and discussion: Sibutramine is an approved medicine and is widely consumed by people, where they feel satiated and lose weight very fast, due to decreased appetite and fat burning. The drug has proven efficacy in weight loss and inadequate consumption, with the lack of healthy eating and physical activity, they present dangers to human health with several adverse effects. Conclusion: The percentage of people who consume sibutramine has grown in recent years, all due to rapid weight loss caused by overweight and obesity. Misuse causes many serious adverse effects. Therefore, before self-medicating, the patient must see a doctor to start the weight loss treatment.
  • 关键词:Consumption;Hazards;Inhibitor;Sibutramine.
国家哲学社会科学文献中心版权所有